Arcturus Therapeutics Holdings (ARCT) Treasury Shares (2018 - 2025)
Arcturus Therapeutics Holdings (ARCT) reported Treasury Shares of $18786.0 for Q4 2025, little changed on a YoY basis from $18786.0 in Q4 2024, and little changed quarter-over-quarter from $18786.0 in Q4 2024.
Arcturus Therapeutics Holdings (ARCT) Treasury Shares (2018 - 2025) Analysis & Trends
Arcturus Therapeutics Holdings has reported Treasury Shares for 5 years, with the latest figure at $18786.0 in Q4 2025.
- For the quarter ending Q4 2025, Treasury Shares changed 0.0% year-over-year to $18786.0; the trailing twelve-month figure through Dec 2025 stood at $18786.0 (changed 0.0% YoY), and the FY2025 full-year result was $18786.0, changed 0.0% from the prior year.
- Treasury Shares for Q4 2025 stood at $18786.0, roughly flat from $18786.0 in the prior quarter.
- The five-year high for Treasury Shares was $18786.0 in Q4 2023, with the low at $18786.0 in Q4 2023.
- Historically, Treasury Shares has averaged $18786.0 across 3 years, with a median of $18786.0 in 2023.
- The largest YoY upside for Treasury Shares was 0.0% in 2024 against a maximum downside of 0.0% in 2024.
- Arcturus Therapeutics Holdings' Treasury Shares stood at $18786.0 in 2023, then changed by 0.0% to $18786.0 in 2024, then changed by 0.0% to $18786.0 in 2025.
- The last three Treasury Shares figures came in at $18786.0 (Q4 2025), $18786.0 (Q4 2024), and $18786.0 (Q4 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 700,000.00 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Arcturus Therapeutics Holdings | 217.14 Mn | 5.76 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 18,786.00 |
| Dec 31, 2025 | 18,786.00 |
| Dec 31, 2024 | 18,786.00 |
| Dec 31, 2024 | 18,786.00 |
| Dec 31, 2023 | 18,786.00 |
| Dec 31, 2023 | 18,786.00 |
| Sep 30, 2019 | -43,000.00 |
| Sep 30, 2019 | -43,000.00 |
| Jun 30, 2019 | -43,000.00 |
| Jun 30, 2019 | -43,000.00 |
| Dec 31, 2018 | 43,000.00 |
| Dec 31, 2018 | 43,000.00 |